Age‐related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.26907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Eun Kyo Ha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, Pneumonia, Mycoplasma, Asthma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Hallym University Research Fund.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Mycoplasma pneumoniae causes community‐acquired pneumonia in children and increases asthma risk, but large studies are lacking.
Objective
To assess the link between M. pneumoniae infection and to asthma exacerbation, in children with allergies, and age of infection impact.
Methods
This retrospective cohort study analyzed medical records of South Korean children between January 2002 and December 2017. The study's exposure was hospitalization with an M. pneumoniae ‐related diagnosis, and the outcome was defined as asthma exacerbation, confirmed by hospitalization at least 6 months after M. pneumoniae infection, with alternative validation using asthma diagnosis and systemic steroid prescription records. Hazard ratios (HRs) for asthma exacerbation risk were estimated for the matched cohort using a Cox proportional hazards model stratified by allergic comorbidities. Time‐dependent covariates and age‐stratified exposure groups were used to calculate odds ratios.
Results
The study included 84,074 children with M. pneumoniae infection and 336,296 unexposed children. Follow‐up for 12.2 ± 2.3 years found the exposed group had a significant risk of asthma exacerbation (HR 2.86, 95% confidence interval [CI] 2.67−3.06) regardless of allergic comorbidities. The risk was highest (over threefold) in children infected between 24 and 71 months. Sensitivity analysis using an alternative definition of the outcome showed an HR of 1.38 (95% CI 1.35−1.42), further supporting the association between M. pneumoniae infection and asthma exacerbation.
Conclusion
M. pneumoniae infection was significantly associated with an increased risk of subsequent asthma exacerbation regardless of allergic comorbidities. Further research needed for understanding and confirmation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea, Seoul, Korea.
- Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, Korea.
- Department of Pediatrics, Bundang CHA Medical Center, CHA University School of Medicine, Seongnam, Korea.
- School of Computer Science and Engineering, Konkuk University, Seoul, Korea.
- Department of Computer Science and Engineering, Sungkyunkwan University, Suwon, Korea.
- Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
ORCID-Profile: Eun Kyo Ha, Ju Hee Kim, Hye Ryeong Cha, Man Yong Han
Förderung
- Hallym University Research Fund
Zitieren
APA
Ha, E. K., Jin, J. O., Kim, J. H., Shin, J., Lee, G. C., Cha, H. R., Choi, S. H., & Han, M. Y. (2024). Age‐related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26907
Vancouver
Ha EK, Jin JO, Kim JH, Shin J, Lee GC, Cha HR, et al. Age‐related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children. Pediatric Pulmonology. 2024. doi:10.1002/ppul.26907
BibTeX
@article{Ha2024,
author = {Ha, Eun Kyo and Jin, Joo Ok and Kim, Ju Hee and Shin, Jeewon and Lee, Gi Chun and Cha, Hye Ryeong and Choi, Sun Hee and Han, Man Yong},
title = {Age‐related effects of Mycoplasma pneumoniae infection and subsequent asthma exacerbation in children},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.26907}
}
EUVIMED